Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Antibodies in mild Coronavirus patients decline rapidly
In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days
California: In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days.
Scientists, including Javier Ibarrondo from the University of California Los Angeles (UCLA), noted that if the declining antibody levels sustained at that rate, they might disappear within about a year. Previous studies had suggested that antibodies which block the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined.
According to the scientists, the current research, published in the New England Journal of Medicine, is the first to carefully estimate the disappearance rate of antibody proteins which are part of the body's humoral immunity.
"Our findings raise concern that humoral immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of persons with Covid-19," the scientists wrote in the research.
In the study, the researchers assessed 20 women and 14 men who recovered from mild cases of COVID-19.
They conducted antibody tests of the patients' blood samples drawn at an average of 36 days and 82 days after the initial symptoms of infection. The scientists said the findings raise concerns about the validity of antibody-based "immunity passports," which are documents that certify a person is immune to COVID-19.
